BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 16336203)

  • 1. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vectors for the treatment of neurodegenerative diseases.
    Martin-Rendon E; Azzouz M; Mazarakis ND
    Curr Opin Mol Ther; 2001 Oct; 3(5):476-81. PubMed ID: 11699892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy.
    Vigna E; Naldini L
    J Gene Med; 2000; 2(5):308-16. PubMed ID: 11045424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors.
    Rahim AA; Wong AM; Howe SJ; Buckley SM; Acosta-Saltos AD; Elston KE; Ward NJ; Philpott NJ; Cooper JD; Anderson PN; Waddington SN; Thrasher AJ; Raivich G
    Gene Ther; 2009 Apr; 16(4):509-20. PubMed ID: 19158847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral vectors for treating and modeling human CNS disorders.
    Azzouz M; Kingsman SM; Mazarakis ND
    J Gene Med; 2004 Sep; 6(9):951-62. PubMed ID: 15352068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vectors in clinical trials: Current status.
    D'Costa J; Mansfield SG; Humeau LM
    Curr Opin Mol Ther; 2009 Oct; 11(5):554-64. PubMed ID: 19806504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus vectors: difficulties and hopes before clinical trials.
    Kafri T
    Curr Opin Mol Ther; 2001 Aug; 3(4):316-26. PubMed ID: 11525555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-primate lentiviral vectors.
    Poeschla EM
    Curr Opin Mol Ther; 2003 Oct; 5(5):529-40. PubMed ID: 14601523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.
    Dreyer JL
    Methods Mol Biol; 2010; 614():3-35. PubMed ID: 20225033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral vectors: turning a deadly foe into a therapeutic agent.
    Trono D
    Gene Ther; 2000 Jan; 7(1):20-3. PubMed ID: 10680011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular gene delivery using lentiviral vectors.
    Balaggan KS; Ali RR
    Gene Ther; 2012 Feb; 19(2):145-53. PubMed ID: 22052240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral vectors as tools to model and treat neurodegenerative disorders.
    Déglon N; Hantraye P
    J Gene Med; 2005 May; 7(5):530-9. PubMed ID: 15651039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
    Van Damme A; Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lentiviral vectors].
    Spirin PV; Vil'gelm AE; Prasolov VS
    Mol Biol (Mosk); 2008; 42(5):913-26. PubMed ID: 18988539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of herpes simplex virus-based vectors for gene delivery to the nervous system.
    Lachmann RH; Efstathiou S
    Mol Med Today; 1997 Sep; 3(9):404-11. PubMed ID: 9302691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy progress and prospects: the eye.
    Bainbridge JW; Tan MH; Ali RR
    Gene Ther; 2006 Aug; 13(16):1191-7. PubMed ID: 16838031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current development of lentiviral-mediated gene transfer.
    Romano G
    Drug News Perspect; 2005 Mar; 18(2):128-34. PubMed ID: 15883621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.